Amanda Halterman, best known for the TLC reality show 1000-Lb Sisters, has dropped more than 300 pounds after undergoing ...
Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...
Halterman made her first appearance on the TLC show in season 4. The older sister of series stars Amy and Tammy Slaton, ...
Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...
The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...
Writer and content creator Jessica Torres pens a personal essay about why it was so significant for her to cut her hair short ...
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 8% in the afternoon session after the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results